Epstein Secrets

sov Christian Angermayer Husodo Angkosubroto Alan Annex Paola Antonelli Platon Antoniou Leo Apot

tor and Presenter Founder and Chief Executive Officer Harvard Kennedy School Airbus SAS Vestas Wind Systems A/S Evonik Industries AG Metabolix Novartis AG JPMorgan Chase & Co. DISH Network USA France Denmark Germany USA Switzerland USA USA Empresa Periodistica El Chile Mercurio SAP Intel C

e Foundation Board of the World Economic Forum Alan Annex Chair, New York Corporate and Greenberg T

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

e Foundation Board of the World Economic Forum Alan Annex Chair, New York Corporate and Greenberg T

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

Eddy Bruyninckx Erik Brynjolfsson Amjad Bseisu Alan Buckle Jorgen Buhl Rasmussen Jerry Buhlmann S

eller & Co. World Vision International Banco BTG Pactual The Financial Times Barclays UNI Global Union University of Miami Xinhua News Agency Novartis AG Bunge Limited Germany France Saudi Arabia USA United Kingdom Switzerland USA USA United Arab Emirates Mexico Saudi Arabia Switzerland U

chael Eisenson - Charlesbank, Managing Partner • Alan Salzman - VantagePoint, Managing Partner ■ Kevin

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

chael Eisenson - Charlesbank, Managing Partner • Alan Salzman - VantagePoint, Managing Partner • Kevin

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

chael Eisenson - Charlesbank, Managing Partner • Alan Salzman - VantagePoint, Managing Partner • Alex

, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te

of the indictment, rejecting defense arguments that it is "unconstitutionally vague." Order attached I Read full article » Boies Denies He Defamed Dershowitz With Epstein Remarks Prominent litigator David Boies hit back Wednesday against defamation counterclaims by embattled attorney Alan Dershowitz, say

e Defamed Dershowitz With Epstein Remarks Prominent litigator David Boies hit back Wednesday against defamation counterclaims by embattled attorney Alan Dershowitz, saying statements he made about Dershowitz's alleged connection to notorious sex offender Jeffrey Epstein were true and protected by the First Ame

C Microsoft Corp. Mitsubishi Motors Corp. National Association for the Advancement of Colored People New York University Nissan Motor Co. Ltd. Novartis AG PNC Financial Services Group Inc. Temple University The Madison Square Garden Co. Trelleborg AB Wal-Mart Stores Inc. Walgreens Co. Yale Univer